# Probiotics and Systemic Inflammation in Patients With Metabolic Syndrome and High Cardiovascular Risk

> **NCT04232852** · NA · WITHDRAWN · sponsor: **Attikon Hospital**

## Conditions studied

- Metabolic Syndrome
- Cardiovascular Risk Factor

## Interventions

- **DIETARY_SUPPLEMENT:** Probiotic mix
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT04232852
- **Lead sponsor:** Attikon Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-06-12
- **Primary completion:** 2021-01-26
- **Final completion:** 2021-01-26
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** lack of funding
- **Last updated:** 2022-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04232852

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04232852, "Probiotics and Systemic Inflammation in Patients With Metabolic Syndrome and High Cardiovascular Risk". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT04232852. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*